3//SEC Filing
VV Manager II, LLC 3
Accession 0000899243-20-025431
CIK 0001818794other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 8:40 PM ET
Size
11.1 KB
Accession
0000899243-20-025431
Insider Transaction Report
Form 3
VV Manager II, LLC
10% Owner
Holdings
- (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (2,087,130 underlying) - (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (57,916 underlying)
Vida Ventures II, LLC
10% Owner
Holdings
- (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (2,087,130 underlying) - (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (57,916 underlying)
VIDA VENTURES II-A, LLC
10% Owner
Holdings
- (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (2,087,130 underlying) - (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (57,916 underlying)
Footnotes (4)
- [F1]The Series B Preferred Stock is convertible into common stock on a 3.3169-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
- [F2]The shares are held directly by Vida Ventures II, LLC ("Vida II"). VV Manager II, LLC ("VV Manager II") is the manager of Vida II. Arie Belldegrun, Fred Cohen, and Leonard Potter are the members of the management committee of VV Manager II (the "Management Committee") and Stefan Vitorovic, Arjun Goyal, Helen Kim, Rajul Jain, and Joshua Kazam are the members of the investment committee of VV Manager II (the "Investment Committee").
- [F3](Continued from footnote 2) Each of the Management Committee, the Investment Committee and the respective members thereof may be deemed to share voting and dispositive power over the shares held by Vida II. VV Manager II, the Management Committee, the Investment Committee and each member of each of the Management Committee and Investment Committee disclaims beneficial ownership over the securities held of record by Vida II and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein.
- [F4]The shares are held directly by Vida Ventures II-A, LLC ("Vida II-A"). VV Manager II is the manager of Vida II-A. Each of the Management Committee, the Investment Committee and the respective members thereof may be deemed to share voting and dispositive power over the shares held by Vida II-A. VV Manager II, the Management Committee, the Investment Committee and each member of each of the Management Committee and Investment Committee disclaims beneficial ownership over the securities held of record by Vida II-A and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001824569
Filing Metadata
- Form type
- 3
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 8:40 PM ET
- Size
- 11.1 KB